Menu
  • Home
  • London Exchange
  • Euronext
  • Australian Exchange
  • Wire
  • Contact Us
  • Business & Finance
NewsnReleases

RooLife & AFT Pharmaceuticals launch online New Zealand health store in China

Posted on July 10, 2020September 7, 2022

PERTH AUSTRALIA: e-Commerce marketing and Artificial Intelligence (AI) company RooLife Group Ltd is appointed by AFT Pharmaceuticals to launch and operate a New Zealand branded health & pharmacy store selling key AFT products on Alibaba’s Tmall platform.

The three-year contract expands RooLife’s Alibaba Tmall revenues and provides RooLife a mixture of monthly service fees and product sales revenue from marketing and selling products within the AFT range. The contract, which is subject to ongoing sales performance milestones, is expected to deliver total revenue for the RooLife Group of approximately $2. 2m over a three year period if minimum sales targets, which are scaled up each year, are met.

The new Kiwi Health store will market and sell a range of health and well-being products online in China leveraging the strong brand awareness of AFT’s product range using the “Kiwi’s thinking about health” branding.

AFT Founder and CEO, Dr Hartley Atkinson says that he is very pleased to further extend the company’s offering to consumers via Online China.

“With a population of over 1.4 billion and with our products already having a strong following by the local Chinese consumer living in New Zealand, we believe that a Tmall flagship store along with amplifying our online presence in China, represents great potential for our health and well-being portfolio’s future growth,” said Dr Atkinson.

RooLife Managing Director, Bryan Carr commented, “Working with AFT Pharmaceuticals to market and sell their well-known, trusted portfolio of health and wellbeing products in the Chinese market under the Kiwi Health banner is an attractive growth opportunity for RooLife. We have seen the successes achieved by large Australian and NZ based pharmacy chains online in China and we are excited by the opportunity available with AFT Pharmaceuticals’ range of products, leveraging the high regard for New Zealand and its products with Chinese shoppers.”

The latest contract is expected to contribute to the continued revenue growth RooLife has achieved in the last 18 months with growth of 490% achieved in FY19 and 380% achieved in FY20. Continuing to build on the strong revenue base achieved in Financial Year 2020, RooLife has announced three new contract wins totalling $6 million in revenue expected this year and over the next two years, subject to the respective minimum sales performance milestones being met.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Track all markets on TradingView

Investing.comThe Exchange Rates are powered by Investing.com.

Site Navigation

  • Home
  • Listed Companies
  • Contact Us
  • London Stock Exchange
  • Singapore Exchange
  • Canadian Exchange
  • Australian Exchange
  • Oslo Bourse
  • PSX
  • Ratings
  • Euronext
  • MENA
  • Nasdaq Nordic
  • Wire
  • Business & Finance
  • Gadget Reviews
  • About Us: A Comprehensive Financial News Database

All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.

Listed Companies

Equity Markets and Stock Exchanges

NNR
©2025 NewsnReleases | WordPress Theme by Superb WordPress Themes
Menu
  • Home
  • London Exchange
  • Euronext
  • Australian Exchange
  • Wire
  • Contact Us
  • Business & Finance